UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059856
Receipt number R000068448
Scientific Title Development of the index to predict the onset of frailty using accelerometers
Date of disclosure of the study information 2025/11/23
Last modified on 2025/11/22 13:48:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of a Triaxial Accelerometer Based Index for Predicting the Onset of Physical Frailty

Acronym

TAFI Study (Triaxial Accelerometer Frailty Index Study)

Scientific Title

Development of the index to predict the onset of frailty using accelerometers

Scientific Title:Acronym

TAFI Study (Triaxial Accelerometer Frailty Index Study)

Region

Japan


Condition

Condition

Community-dwelling older adults and older patients without physical activity limitations

Classification by specialty

Medicine in general Hepato-biliary-pancreatic medicine Endocrinology and Metabolism
Rehabilitation medicine Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In this study, we will evaluate 24-hour movement behaviors (physical activity, sedentary behavior, and sleep) in community-dwelling older adults and older patients without limitations in physical activity, and examine their association with physical frailty (sarcopenia).

Basic objectives2

Others

Basic objectives -Others

To develop and validate a triaxial accelerometer based index using 24 hour movement behavior data for predicting the onset of physical frailty (sarcopenia) in community dwelling older adults and older patients without limitations in physical activity.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The primary outcome will be physical frailty (sarcopenia), and the primary exposure variable will be movement data assessed using a wrist-worn triaxial accelerometer. Secondary outcomes will include components of physical frailty (sarcopenia): appendicular skeletal muscle mass, handgrip strength, gait speed, five times sit to stand time, and lower limb muscle strength: as well as health-related quality of life and related measures.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit

89 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Individuals who are fully independent in all activities of daily living, as indicated by a full score on the Barthel Index.
2. Individuals who, after receiving sufficient explanation about this study and adequately understanding its content, provide consent to participate of their own free will.

Key exclusion criteria

The following individuals will be excluded from this study:
1. Individuals who have disorders of the locomotor system or impaired motor function and are attending a medical facility for this reason.
2. Individuals with an implanted cardiac pacemaker.
In addition, for patients attending an outpatient clinic for internal medicine conditions such as hypertension or dyslipidemia, the following criteria (3 and 4) will also be applied in addition to the above criteria 1 and 2:
3. Individuals whose physical activity is restricted by their attending physician.
4. Individuals whom the principal investigator judges to be otherwise inappropriate for inclusion in this study.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Takuo
Middle name
Last name Nomura

Organization

Kansai Medical University

Division name

Faculty of Rehabilitation

Zip code

573-1136

Address

18-89, Higasi-machi, Uyama, Hirakata city, Osaka

TEL

072-856-2115

Email

tnomura@ymail.ne.jp


Public contact

Name of contact person

1st name Takuo
Middle name
Last name Nomura

Organization

Kansai Medical University

Division name

Faculty of Rehabilitation

Zip code

573-1136

Address

18-89, Higasi-machi, Uyama, Hirakata city, Osaka

TEL

072-856-2115

Homepage URL


Email

tnomura@ymail.ne.jp


Sponsor or person

Institute

Kansai Medical University, Faculty of Rehabilitation

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Review Board of Kansai Medical University

Address

2-5-1, Shin-machi, Hirakata city, Osaka

Tel

072-804-2440

Email

rinriirb@hirakata.kmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 11 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 05 Month 12 Day

Date of IRB

2022 Year 05 Month 12 Day

Anticipated trial start date

2022 Year 09 Month 13 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Collaborating institutions: Tokyo Metropolitan Institute for Geriatrics and Gerontology (Tokyo, Japan), Juntendo University (Tokyo, Japan), Okayama Healthcare Professional University (Okayama, Japan), KKR Takamatsu Hospital (Kagawa, Japan), Misaki Internal Medicine Clinic (Chiba, Japan), and Kansai University of Welfare Sciences (Osaka, Japan).


Management information

Registered date

2025 Year 11 Month 22 Day

Last modified on

2025 Year 11 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068448